Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer.

Saved in:
Bibliographic Details
Title: Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer.
Authors: Taza, Fadi1,2 (AUTHOR), Holler, Albert E.1 (AUTHOR), Fu, Wei1 (AUTHOR), Wang, Hao1 (AUTHOR), Adra, Nabil3 (AUTHOR), Albany, Costantine3 (AUTHOR), Ashkar, Ryan3 (AUTHOR), Cheng, Heather H.4 (AUTHOR), Sokolova, Alexandra O.4 (AUTHOR), Agarwal, Neeraj5 (AUTHOR), Kessel, Adam5 (AUTHOR), Bryce, Alan6 (AUTHOR), Nafissi, Nellie6 (AUTHOR), Barata, Pedro7 (AUTHOR), Sartor, A. Oliver7 (AUTHOR), Bastos, Diogo8 (AUTHOR), Smaletz, Oren9 (AUTHOR), Berchuck, Jacob E.10 (AUTHOR), Taplin, Mary-Ellen10 (AUTHOR), Aggarwal, Rahul11 (AUTHOR)
Source: JCO Precision Oncology. 7/22/2021, Vol. 5, p1200-1220. 21p.
Database: Academic Search Ultimate
Description
ISSN:24734284
DOI:10.1200/PO.21.00070